Ondansetron Injection
Product Images NDC 71872-7107

3 FDA label images from Medical Purchasing Solutions, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 71872-7107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (7107)

Pdp (7107)
Ondansetron Injection USP 40 mg/20 mL (2 mg/mL) multiple dose vial label. The vial contains 20 mL of injectable solution, for intravenous or intramuscular administration. Distributed by Medical Purchasing Solutions, Scottsdale, AZ. The label includes dosage strength, storage instructions between 20° to 25°C, and indicates sterility and usual dosage directions. Lot number and expiration are placeholders.*
FDA Label Image

Structural Formula (Ondansetron Injection 1)

Structural Formula (Ondansetron Injection 1)
Chemical structure of Ondansetron hydrochloride dihydrate depicted as a molecular diagram, showing its fused ring system including an indole and a methyl-substituted imidazole ring connected by a carbonyl group, with associated chloride and water molecules.*
FDA Label Image

Ndc 0143-9890-01 Ondansetron Injection, Usp 40 mg/20 mL (2 mg/ml) Sterile For Iv Or Im Use Rx Only 20 mL Multiple Dose Vial Each 1 mL Of Aqueous Solution In The 20 mL Multidose Vial Contains 2 mg Of O (Ondansetron Injection 3)

Ndc 0143-9890-01 Ondansetron Injection, Usp 40 mg/20 mL (2 mg/ml) Sterile For Iv Or Im Use Rx Only 20 mL Multiple Dose Vial Each 1 mL Of Aqueous Solution In The 20 mL Multidose Vial Contains 2 mg Of O (Ondansetron Injection 3)
Ondansetron Injection, USP 40 mg/20 mL (2 mg/mL) sterile solution for intravenous or intramuscular use. The multiple-dose vial label shows active ingredient concentration and dosage form, storage instructions, and preservatives. Manufactured by Hikma Farmacéutica (Portugal) and distributed by West-Ward Pharmaceutical Corp, Easton, NJ. Rx only, with barcode and lot/expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.